Search Results - "Aubeneau, M"

  • Showing 1 - 4 results of 4
Refine Results
  1. 1

    Effect of age and gender on the pharmacokinetics of ebastine after single and repeated dosing in healthy subjects by Rohatagi, S, Gillen, M, Aubeneau, M, Jan, C, Pandit, B, Jensen, B K, Rhodes, G

    “…Ebastine is a potent and selective H1-receptor antagonist indicated for allergic rhinitis which undergoes extensive first pass metabolism by CYP3A4 to form an…”
    Get more information
    Journal Article
  2. 2

    Single- and Multiple-Dose Pharmacokinetics of Riluzole in White Subjects by Liboux, Aimé Le, Lefebvre, Patricia, Roux, Yvonne Le, Truffinet, Philippe, Aubeneau, Michel, Kirkesseli, Stéphane, Montay, Guy

    Published in Journal of clinical pharmacology (01-09-1997)
    “…Riluzole is a novel neuroprotective agent that has been developed for the treatment of amyotrophic lateral sclerosis. A series of studies was undertaken to…”
    Get full text
    Journal Article Conference Proceeding
  3. 3

    Differential effects of potassium channel blockers on dopamine release from rat striatal slices by Boireau, A, Richard, F, Olivier, V, Aubeneau, M, Miquet, J M, Dubédat, P, Laduron, P, Doble, A, Blanchard, J C

    Published in Journal of pharmacy and pharmacology (01-11-1991)
    “…The effects of different potassium channel blockers on tritiated dopamine [( 3H]DA) release were investigated in rat striatal slices in the presence of…”
    Get more information
    Journal Article
  4. 4

    Potassium markedly potentiates the effect of veratridine on dopamine release from rat superfused striatal ribbons by Olivier, V, Miquet, J M, Aubeneau, M, Blanchard, J C, Doble, A, Boireau, A

    Published in Journal of pharmacy and pharmacology (01-01-1992)
    “…The effects of veratridine-induced depolarization on [3H]dopamine ([3H]DA) release in the presence of a physiological (5 mM) or a depolarizing (25 mM)…”
    Get more information
    Journal Article